- Adults with uncontrolled high blood pressure were about half as likely to have serious cardiovascular events in the five years after a pharmacist-led telemonitoring program compared to those receiving routine primary care.
- By reducing cardiovascular events, the telemonitoring intervention saved about $1,900 over five years in overall health care costs for each individual.
Embargoed until 4 a.m. CT/5 a.m. ET Monday, August 31, 2020
DALLAS, August 31, 2020 — People enrolled in a pharmacist-led telemonitoring program to control high blood pressure were about half as likely to have a heart attack or stroke compared to those who received routine primary care, according to new research published today in Hypertension, an American Heart Association journal.
Researchers, led by study author Karen L. Margolis, M.D., M.P.H., executive director of research at HealthPartners Institute in Minneapolis, Minn., found that a heart attack, stroke, stent placement or heart failure hospitalization occurred in 5.3% of the telemonitoring group vs. 10.4% of the routine primary care group.
“Home blood pressure monitoring linked with treatment actions from the health care team delivered remotely (telehealth support) in between office visits has been shown to lower blood pressure more than routine care, and patients really like it,” said Margolis. “In addition, by avoiding serious cardiovascular events over 5 years, our results indicate significant cost savings.” Patients reported that they liked having support from a trusted professional, rapid feedback and adjustments to their treatment, and having someone to be accountable to.
Margolis reports that over 5 years, the savings from reduced cardiovascular disease events exceeded the telemonitoring intervention costs by $1,900 per patient.
“The findings were just short of statistical significance,” said Margolis, “meaning they could have been due to chance. However, we were surprised that the figures on serious cardiovascular events pointed so strongly to a benefit of the telemonitoring intervention,” she said.
Uncontrolled high blood pressure is the largest modifiable risk factor contributing to death from all causes. Nearly half of U.S. adults have high blood pressure, defined as equal to or greater than 130 mm Hg systolic (top number), or 80 mm Hg diastolic (bottom number). However, most adults with high blood pressure don’t have their numbers under control.
450 participants with uncontrolled high blood pressure were enrolled in the study, conducted at 16 primary care clinics within the HealthPartners system in Minnesota. Participants were blinded and randomized to two groups: 222 patients were in the routine primary care group, and 228 in the telemonitoring group that also received one year of remote care managed by a pharmacist. In the telemonitoring group, patients were able to measure their blood pressure at home and send it electronically to the pharmacist, who then worked with them to make medication and lifestyle changes in their treatment.
In clinic visits for all participants, researchers monitored blood pressure at enrollment, 6 months, 12 months, 18 months and 5 years; kept track of any heart attacks, strokes, coronary stents, heart failure hospitalizations and heart-related deaths that occurred; and counted all the costs of their blood pressure-related care and cardiovascular event care.
- In the telemonitoring group, there were 15 serious cardiovascular events (5 non-fatal heart attacks, 4 non-fatal strokes, 5 heart failure hospitalizations, 1 CV death) among 10 patients. This group also had 2 stent placements, making the total event rate 5.3%.
- In the routine primary care group, there were 26 serious cardiovascular events (11 non-fatal heart attacks, 12 non-fatal strokes, 3 heart failure hospitalizations) among 19 patients. They also had 10 stent placements, making the total event rate 10.4%.
Based on these findings, “widespread adoption of the telemonitoring model might help U.S. adults with uncontrolled high blood pressure avoid serious cardiovascular events and reduce health care costs,” according to Margolis and colleagues. They recommend future studies to figure out how to increase the number of patients engaged in home blood pressure monitoring over many years, and to measure cardiovascular risk factors and cardiovascular events over that extended period.
The study’s limitations are its relatively small size, and it was at a single medical group’s urban and suburban primary care clinics, which may not represent the diversity of patients who receive care in other settings across the country.
Co-authors are Steven P. Dehmer, Ph.D.; JoAnn Sperl-Hillen, M.D.; Patrick J. O’Connor, M.D., M.P.H.; Stephen E. Asche, M.A.; Anna R. Bergdall, M.P.H.; Beverly B. Green, M.D., M.P.H.; Rachel A. Nyboer, B.A.; Pamala A. Pawloski, Pharm.D.; Nicole K. Trower, B.A.; and Michael V. Maciosek, Ph.D. The authors reported no disclosures.
The National Heart, Lung, and Blood Institute of the National Institutes of Health funded the study.
- Available multimedia is on right column of release link - https://newsroom.heart.org/news/for-people-with-high-blood-pressure-telemonitoring-may-cut-heart-attack-stroke-rate-by-50?preview=7663ad661fd1d05ba23a84f9173fd3ed
- After 4 a.m. CT/ 5 a.m. ET, Monday, August 31, 2020, view the manuscript online.
- Learn how to monitor your blood pressure at home.
- Target: BP helps healthcare organizations and care teams, at no cost, improve blood pressure control rates.
- Follow AHA/ASA news on Twitter @HeartNews
- Follow news from the AHA’s Hypertension journal @HyperAHA
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective:
Maggie Francis: 214-706-1382, firstname.lastname@example.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)